Physician profile
Sameer Farooq
NPI 1366939787
$1,363.13
in general payments reported to CMS, 2019-2025
22 companies · $1,070 in 2025
The $1,070 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $33.05 · 2024: $261 · 2025: $1,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,363.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $260.59 | 2024-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $164.67 | 2025 | |
| Ferring Pharmaceuticals INC. | $138.97 | 2024-2025 | Adstiladrin |
| Blue Earth Diagnostics | $118.68 | 2024-2025 | Posluma |
| Astellas Pharma US INC | $70.71 | 2025 | Xtandi |
| Janssen Biotech, INC. | $66.58 | 2024-2025 | Erleada |
| Tolmar, INC. | $61.80 | 2024-2025 | Jatenzo, Eligard |
| Myriad Genetic Laboratories, INC. | $56.60 | 2024-2025 | Prolaris, Myrisk |
| Civco Medical Instruments | $46.28 | 2025 | |
| Coloplast Corp | $41.91 | 2025 | |
| Teleflex LLC | $40.83 | 2025 | Barrigel |
| Urogen Pharma, INC. | $36.19 | 2025 | |
| Convatec INC. | $33.05 | 2023 | |
| Abbvie INC. | $32.45 | 2024-2025 | |
| Telix Pharmaceuticals | $31.46 | 2025 | Illuccix |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih Ab | $29.16 | 2025 | Lofric |
| Laborie Medical Technologies Corp. | $29.00 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Merck Sharp & Dohme LLC | $22.86 | 2024 | Lynparza |
| Dendreon Pharmaceuticals LLC | $22.13 | 2025 | Provenge |
| Olympus America INC. | $21.29 | 2025 | Itind System |
| Pfizer INC. | $19.53 | 2025 | |
| Tempus Ai, INC | $18.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Farooq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.